APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Modulators

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025196 pages

Choose your research edition.

Industry ResearchGABA Receptor Modulators Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Modulators Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Modulators Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Modulators Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global GABA Receptor Modulators market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABA Receptor Modulators include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sanofi, Novartis, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GABA Receptor Modulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABA Receptor Modulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA Receptor Modulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA Receptor Modulators market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA Receptor Modulators Segment by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

Sandoz

SAGE Therapeutics

Neurelis

Jazz Pharmaceuicals

Hikma

CHEPLAPHARM

Apotex

Akorn

GABA Receptor Modulators Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

GABA Receptor Modulators Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABA Receptor Modulators Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA Receptor Modulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABA Receptor Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GABA Receptor Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GABA Receptor Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GABA Receptor Modulators Industry Trends Table 2. GABA Receptor Modulators Industry Drivers Table 3. GABA Receptor Modulators Industry Opportunities and Challenges Table 4. GABA Receptor Modulators Industry Restraints Table 5. Global GABA Receptor Modulators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GABA Receptor Modulators Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GABA Receptor Modulators Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global GABA Receptor Modulators Sales Market Share by Manufacturers Table 9. Global GABA Receptor Modulators Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global GABA Receptor Modulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GABA Receptor Modulators Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GABA Receptor Modulators Manufacturers, Product Type & Application Table 13. Global GABA Receptor Modulators Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA Receptor Modulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of GABAA Receptors Table 17. Major Manufacturers of GABAB Receptors Table 18. Major Manufacturers of GABAC Receptors Table 19. Global GABA Receptor Modulators Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 21. Global GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 22. Global GABA Receptor Modulators Sales Market Share by Type (2021-2026) Table 23. Global GABA Receptor Modulators Sales Market Share by Type (2027-2032) Table 24. Global GABA Receptor Modulators Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global GABA Receptor Modulators Revenue by Type (2021-2026) & (K Units) Table 26. Global GABA Receptor Modulators Revenue by Type (2027-2032) & (K Units) Table 27. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2026) Table 28. Global GABA Receptor Modulators Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Epilepsy Table 30. Major Manufacturers of Anxiety Table 31. Major Manufacturers of Neuropathic Pain Table 32. Major Manufacturers of Insomnia Table 33. Major Manufacturers of Other Table 34. Global GABA Receptor Modulators Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 36. Global GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 37. Global GABA Receptor Modulators Sales Market Share by Application (2021-2026) Table 38. Global GABA Receptor Modulators Sales Market Share by Application (2027-2032) Table 39. Global GABA Receptor Modulators Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global GABA Receptor Modulators Revenue by Application (2021-2026) & (K Units) Table 41. Global GABA Receptor Modulators Revenue by Application (2027-2032) & (K Units) Table 42. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2026) Table 43. Global GABA Receptor Modulators Revenue Market Share by Application (2027-2032) Table 44. Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global GABA Receptor Modulators Sales by Region (2021-2026) & (K Units) Table 46. Global GABA Receptor Modulators Sales Market Share by Region (2021-2026) Table 47. Global GABA Receptor Modulators Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global GABA Receptor Modulators Sales Forecasted Market Share by Region (2027-2032) Table 49. North America GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 51. North America GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 52. Europe GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 54. Europe GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 61. Global GABA Receptor Modulators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global GABA Receptor Modulators Revenue by Region (2021-2026) & (US$ Million) Table 63. Global GABA Receptor Modulators Revenue by Region (2027-2032) & (US$ Million) Table 64. Global GABA Receptor Modulators Revenue Market Share by Region (2021-2026) Table 65. Global GABA Receptor Modulators Revenue Market Share by Region (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Takeda GABA Receptor Modulators Product Portfolio Table 70. Takeda Recent Development Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Teva GABA Receptor Modulators Product Portfolio Table 75. Teva Recent Development Table 76. Sun Pharma Company Information Table 77. Sun Pharma Business Overview Table 78. Sun Pharma GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sun Pharma GABA Receptor Modulators Product Portfolio Table 80. Sun Pharma Recent Development Table 81. Shanghai Pharmaceuticals Holding Company Information Table 82. Shanghai Pharmaceuticals Holding Business Overview Table 83. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio Table 85. Shanghai Pharmaceuticals Holding Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanofi GABA Receptor Modulators Product Portfolio Table 90. Sanofi Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Novartis GABA Receptor Modulators Product Portfolio Table 95. Novartis Recent Development Table 96. Mylan Company Information Table 97. Mylan Business Overview Table 98. Mylan GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Mylan GABA Receptor Modulators Product Portfolio Table 100. Mylan Recent Development Table 101. Roche Company Information Table 102. Roche Business Overview Table 103. Roche GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Roche GABA Receptor Modulators Product Portfolio Table 105. Roche Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Pfizer GABA Receptor Modulators Product Portfolio Table 110. Pfizer Recent Development Table 111. Huazhong Pharmaceutical Company Information Table 112. Huazhong Pharmaceutical Business Overview Table 113. Huazhong Pharmaceutical GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio Table 115. Huazhong Pharmaceutical Recent Development Table 116. Sichuan HaiscoPharmaceuical Company Information Table 117. Sichuan HaiscoPharmaceuical Business Overview Table 118. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio Table 120. Sichuan HaiscoPharmaceuical Recent Development Table 121. GSK Company Information Table 122. GSK Business Overview Table 123. GSK GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. GSK GABA Receptor Modulators Product Portfolio Table 125. GSK Recent Development Table 126. Fresenius Kabi Company Information Table 127. Fresenius Kabi Business Overview Table 128. Fresenius Kabi GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Fresenius Kabi GABA Receptor Modulators Product Portfolio Table 130. Fresenius Kabi Recent Development Table 131. Changzhou Siyao Pharmaceutical Company Information Table 132. Changzhou Siyao Pharmaceutical Business Overview Table 133. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio Table 135. Changzhou Siyao Pharmaceutical Recent Development Table 136. AstraZeneca Company Information Table 137. AstraZeneca Business Overview Table 138. AstraZeneca GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. AstraZeneca GABA Receptor Modulators Product Portfolio Table 140. AstraZeneca Recent Development Table 141. WG Critical Care Company Information Table 142. WG Critical Care Business Overview Table 143. WG Critical Care GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. WG Critical Care GABA Receptor Modulators Product Portfolio Table 145. WG Critical Care Recent Development Table 146. Viatris Company Information Table 147. Viatris Business Overview Table 148. Viatris GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Viatris GABA Receptor Modulators Product Portfolio Table 150. Viatris Recent Development Table 151. Torrent Pharma Company Information Table 152. Torrent Pharma Business Overview Table 153. Torrent Pharma GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Torrent Pharma GABA Receptor Modulators Product Portfolio Table 155. Torrent Pharma Recent Development Table 156. Sandoz Company Information Table 157. Sandoz Business Overview Table 158. Sandoz GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Sandoz GABA Receptor Modulators Product Portfolio Table 160. Sandoz Recent Development Table 161. SAGE Therapeutics Company Information Table 162. SAGE Therapeutics Business Overview Table 163. SAGE Therapeutics GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. SAGE Therapeutics GABA Receptor Modulators Product Portfolio Table 165. SAGE Therapeutics Recent Development Table 166. Neurelis Company Information Table 167. Neurelis Business Overview Table 168. Neurelis GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Neurelis GABA Receptor Modulators Product Portfolio Table 170. Neurelis Recent Development Table 171. Jazz Pharmaceuicals Company Information Table 172. Jazz Pharmaceuicals Business Overview Table 173. Jazz Pharmaceuicals GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio Table 175. Jazz Pharmaceuicals Recent Development Table 176. Hikma Company Information Table 177. Hikma Business Overview Table 178. Hikma GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Hikma GABA Receptor Modulators Product Portfolio Table 180. Hikma Recent Development Table 181. CHEPLAPHARM Company Information Table 182. CHEPLAPHARM Business Overview Table 183. CHEPLAPHARM GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. CHEPLAPHARM GABA Receptor Modulators Product Portfolio Table 185. CHEPLAPHARM Recent Development Table 186. Apotex Company Information Table 187. Apotex Business Overview Table 188. Apotex GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. Apotex GABA Receptor Modulators Product Portfolio Table 190. Apotex Recent Development Table 191. Akorn Company Information Table 192. Akorn Business Overview Table 193. Akorn GABA Receptor Modulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. Akorn GABA Receptor Modulators Product Portfolio Table 195. Akorn Recent Development Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. GABA Receptor Modulators Distributors List Table 199. GABA Receptor Modulators Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. GABA Receptor Modulators Product Image Figure 2. Global GABA Receptor Modulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Modulators Market Size (2021-2032) & (US$ Million) Figure 4. Global GABA Receptor Modulators Sales (2021-2032) & (K Units) Figure 5. Global GABA Receptor Modulators Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 GABA Receptor Modulators Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. GABAA Receptors Image Figure 9. GABAB Receptors Image Figure 10. GABAC Receptors Image Figure 11. Global GABA Receptor Modulators Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global GABA Receptor Modulators Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global GABA Receptor Modulators Sales Market Share by Type (2021-2032) Figure 14. Global GABA Receptor Modulators Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global GABA Receptor Modulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032) Figure 17. Epilepsy Image Figure 18. Anxiety Image Figure 19. Neuropathic Pain Image Figure 20. Insomnia Image Figure 21. Other Image Figure 22. Global GABA Receptor Modulators Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global GABA Receptor Modulators Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global GABA Receptor Modulators Sales Market Share by Application (2021-2032) Figure 25. Global GABA Receptor Modulators Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global GABA Receptor Modulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032) Figure 28. North America GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 30. U.S. GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 35. Germany GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 42. China GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 50. Brazil GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile GABA Receptor Modulators Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global GABA Receptor Modulators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global GABA Receptor Modulators Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Figure 61. North America GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Figure 63. Europe GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa GABA Receptor Modulators Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. GABA Receptor Modulators Value Chain Figure 69. Manufacturing Cost Structure Figure 70. GABA Receptor Modulators Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • Sandoz
  • SAGE Therapeutics
  • Neurelis
  • Jazz Pharmaceuicals
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GABA Receptor Modulators Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GABA Receptor Modulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GABA Receptor Modulators Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GABA Receptor Modulators Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GABA Receptor Modulators Market Dynamics
  1. 2.1 GABA Receptor Modulators Industry Trends
  2. 2.2 GABA Receptor Modulators Industry Drivers
  3. 2.3 GABA Receptor Modulators Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Modulators Industry Restraints
3 GABA Receptor Modulators Market by Manufacturers
  1. 3.1 Global GABA Receptor Modulators Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GABA Receptor Modulators Sales by Manufacturers (2021-2026)
  3. 3.3 Global GABA Receptor Modulators Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GABA Receptor Modulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABA Receptor Modulators Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GABA Receptor Modulators Manufacturers, Product Type & Application
  7. 3.7 Global GABA Receptor Modulators Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABA Receptor Modulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABA Receptor Modulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABA Receptor Modulators Tier 1, Tier 2, and Tier 3
4 GABA Receptor Modulators Market by Type
  1. 4.1 GABA Receptor Modulators Type Introduction
  2. 4.1.1 GABAA Receptors
  3. 4.1.2 GABAB Receptors
  4. 4.1.3 GABAC Receptors
  5. 4.2 Global GABA Receptor Modulators Sales by Type
  6. 4.2.1 Global GABA Receptor Modulators Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GABA Receptor Modulators Sales by Type (2021-2032)
  8. 4.2.3 Global GABA Receptor Modulators Sales Market Share by Type (2021-2032)
  9. 4.3 Global GABA Receptor Modulators Revenue by Type
  10. 4.3.1 Global GABA Receptor Modulators Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GABA Receptor Modulators Revenue by Type (2021-2032)
  12. 4.3.3 Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032)
5 GABA Receptor Modulators Market by Application
  1. 5.1 GABA Receptor Modulators Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global GABA Receptor Modulators Sales by Application
  8. 5.2.1 Global GABA Receptor Modulators Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global GABA Receptor Modulators Sales by Application (2021-2032)
  10. 5.2.3 Global GABA Receptor Modulators Sales Market Share by Application (2021-2032)
  11. 5.3 Global GABA Receptor Modulators Revenue by Application
  12. 5.3.1 Global GABA Receptor Modulators Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global GABA Receptor Modulators Revenue by Application (2021-2032)
  14. 5.3.3 Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032)
6 Global GABA Receptor Modulators Sales by Region
  1. 6.1 Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA Receptor Modulators Sales by Region (2021-2032)
  3. 6.2.1 Global GABA Receptor Modulators Sales by Region (2021-2026)
  4. 6.2.2 Global GABA Receptor Modulators Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GABA Receptor Modulators Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GABA Receptor Modulators Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GABA Receptor Modulators Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GABA Receptor Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GABA Receptor Modulators Revenue by Region
  1. 7.1 Global GABA Receptor Modulators Revenue by Region
  2. 7.1.1 Global GABA Receptor Modulators Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GABA Receptor Modulators Revenue by Region (2021-2026)
  4. 7.1.3 Global GABA Receptor Modulators Revenue by Region (2027-2032)
  5. 7.1.4 Global GABA Receptor Modulators Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GABA Receptor Modulators Revenue (2021-2032)
  8. 7.2.2 North America GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GABA Receptor Modulators Revenue (2021-2032)
  11. 7.3.2 Europe GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GABA Receptor Modulators Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GABA Receptor Modulators Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GABA Receptor Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda GABA Receptor Modulators Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva GABA Receptor Modulators Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma GABA Receptor Modulators Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
  19. 8.4 Shanghai Pharmaceuticals Holding
  20. 8.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 8.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 8.4.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio
  24. 8.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi GABA Receptor Modulators Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis GABA Receptor Modulators Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan GABA Receptor Modulators Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche GABA Receptor Modulators Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer GABA Receptor Modulators Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Huazhong Pharmaceutical
  56. 8.10.1 Huazhong Pharmaceutical Company Information
  57. 8.10.2 Huazhong Pharmaceutical Business Overview
  58. 8.10.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio
  60. 8.10.5 Huazhong Pharmaceutical Recent Developments
  61. 8.11 Sichuan HaiscoPharmaceuical
  62. 8.11.1 Sichuan HaiscoPharmaceuical Company Information
  63. 8.11.2 Sichuan HaiscoPharmaceuical Business Overview
  64. 8.11.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio
  66. 8.11.5 Sichuan HaiscoPharmaceuical Recent Developments
  67. 8.12 GSK
  68. 8.12.1 GSK Company Information
  69. 8.12.2 GSK Business Overview
  70. 8.12.3 GSK GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GSK GABA Receptor Modulators Product Portfolio
  72. 8.12.5 GSK Recent Developments
  73. 8.13 Fresenius Kabi
  74. 8.13.1 Fresenius Kabi Company Information
  75. 8.13.2 Fresenius Kabi Business Overview
  76. 8.13.3 Fresenius Kabi GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Fresenius Kabi GABA Receptor Modulators Product Portfolio
  78. 8.13.5 Fresenius Kabi Recent Developments
  79. 8.14 Changzhou Siyao Pharmaceutical
  80. 8.14.1 Changzhou Siyao Pharmaceutical Company Information
  81. 8.14.2 Changzhou Siyao Pharmaceutical Business Overview
  82. 8.14.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio
  84. 8.14.5 Changzhou Siyao Pharmaceutical Recent Developments
  85. 8.15 AstraZeneca
  86. 8.15.1 AstraZeneca Company Information
  87. 8.15.2 AstraZeneca Business Overview
  88. 8.15.3 AstraZeneca GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AstraZeneca GABA Receptor Modulators Product Portfolio
  90. 8.15.5 AstraZeneca Recent Developments
  91. 8.16 WG Critical Care
  92. 8.16.1 WG Critical Care Company Information
  93. 8.16.2 WG Critical Care Business Overview
  94. 8.16.3 WG Critical Care GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 WG Critical Care GABA Receptor Modulators Product Portfolio
  96. 8.16.5 WG Critical Care Recent Developments
  97. 8.17 Viatris
  98. 8.17.1 Viatris Company Information
  99. 8.17.2 Viatris Business Overview
  100. 8.17.3 Viatris GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Viatris GABA Receptor Modulators Product Portfolio
  102. 8.17.5 Viatris Recent Developments
  103. 8.18 Torrent Pharma
  104. 8.18.1 Torrent Pharma Company Information
  105. 8.18.2 Torrent Pharma Business Overview
  106. 8.18.3 Torrent Pharma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Torrent Pharma GABA Receptor Modulators Product Portfolio
  108. 8.18.5 Torrent Pharma Recent Developments
  109. 8.19 Sandoz
  110. 8.19.1 Sandoz Company Information
  111. 8.19.2 Sandoz Business Overview
  112. 8.19.3 Sandoz GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sandoz GABA Receptor Modulators Product Portfolio
  114. 8.19.5 Sandoz Recent Developments
  115. 8.20 SAGE Therapeutics
  116. 8.20.1 SAGE Therapeutics Company Information
  117. 8.20.2 SAGE Therapeutics Business Overview
  118. 8.20.3 SAGE Therapeutics GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SAGE Therapeutics GABA Receptor Modulators Product Portfolio
  120. 8.20.5 SAGE Therapeutics Recent Developments
  121. 8.21 Neurelis
  122. 8.21.1 Neurelis Company Information
  123. 8.21.2 Neurelis Business Overview
  124. 8.21.3 Neurelis GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Neurelis GABA Receptor Modulators Product Portfolio
  126. 8.21.5 Neurelis Recent Developments
  127. 8.22 Jazz Pharmaceuicals
  128. 8.22.1 Jazz Pharmaceuicals Company Information
  129. 8.22.2 Jazz Pharmaceuicals Business Overview
  130. 8.22.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio
  132. 8.22.5 Jazz Pharmaceuicals Recent Developments
  133. 8.23 Hikma
  134. 8.23.1 Hikma Company Information
  135. 8.23.2 Hikma Business Overview
  136. 8.23.3 Hikma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Hikma GABA Receptor Modulators Product Portfolio
  138. 8.23.5 Hikma Recent Developments
  139. 8.24 CHEPLAPHARM
  140. 8.24.1 CHEPLAPHARM Company Information
  141. 8.24.2 CHEPLAPHARM Business Overview
  142. 8.24.3 CHEPLAPHARM GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 CHEPLAPHARM GABA Receptor Modulators Product Portfolio
  144. 8.24.5 CHEPLAPHARM Recent Developments
  145. 8.25 Apotex
  146. 8.25.1 Apotex Company Information
  147. 8.25.2 Apotex Business Overview
  148. 8.25.3 Apotex GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Apotex GABA Receptor Modulators Product Portfolio
  150. 8.25.5 Apotex Recent Developments
  151. 8.26 Akorn
  152. 8.26.1 Akorn Company Information
  153. 8.26.2 Akorn Business Overview
  154. 8.26.3 Akorn GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Akorn GABA Receptor Modulators Product Portfolio
  156. 8.26.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA Receptor Modulators Value Chain Analysis
  2. 9.1.1 GABA Receptor Modulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA Receptor Modulators Production Mode & Process
  6. 9.2 GABA Receptor Modulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA Receptor Modulators Distributors
  9. 9.2.3 GABA Receptor Modulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst